BHV-4157

Phase 3Small molecule

BBiohaven Therapeutics Ltd.

BHV-4157 is one of 53 small molecule programs targeting Cerebellar Ataxia. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cerebellar AtaxiaActive, not recruiting

TrialActive, not recruiting

Cerebellar AtaxiaPreclinical

Active, not recruiting

TrialPhase 3

Active, not recruiting

Competition

Competitive Landscape

139 competitors in Trial

#DrugCompanyPhaseTrials

Opdivo

Bristol-Myers Squibb

Phase 3

4 2

Yervoy

Bristol-Myers Squibb

Phase 3

3 3

Camptosar

Pfizer

Phase 3

2 4

Eloxatin

Teva

Phase 3

2 5

Vectibix

Amgen

Phase 3

2 6

Perjeta

Roche

Phase 3

2 7

Platinol

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Phase 3

5 8

Tarceva

OOSI Pharmaceuticals

Phase 3

5 9

Herceptin

OOrganon and Co

Phase 3

4 10

Adrucil

EElorac, Inc.

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Trial1 trial

Open Pilot Trial of BHV-4157

Active, not recruiting·UUniversity of California, Los Angeles·Phase 3·NCT03408080·24 enrolled

Cerebellar Ataxia1 trial

Real-World Data Study of Troriluzole-Treated Patients With Spinocerebellar Ataxia (SCA) Compared to a Matched Natural History Control

Active, not recruiting·BBiohaven Therapeutics Ltd.··NCT06529146·909 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for BHV-4157. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — BHV-4157 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for BHV-4157. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Biohaven Therapeutics Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: BBiohaven Therapeutics Ltd.

BHV-4157

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Trial1 trial

Cerebellar Ataxia1 trial

References

Drug Info

Quick Facts

Related News